Citation: A. Guglietta, Inflammatory and ulcerative conditions of the gastrointestinal tract: Pathogenesis prevention and treatment - Preface, CUR PHARM D, 7(1), 2001, pp. NIL_4-NIL_5
Citation: Md. Barrachina et al., Role of nitric oxide in gastrointestinal inflammatory and ulcerative diseases: Perspective for drugs development, CUR PHARM D, 7(1), 2001, pp. 31-48
Authors:
Takeuchi, K
Tanaka, A
Suzuki, K
Mizoguchi, H
Citation: K. Takeuchi et al., Gastrointestinal sparing anti-inflammatory drugs - Effects on ulcerogenic and healing responses, CUR PHARM D, 7(1), 2001, pp. 49-69
Citation: K. Muller, Current status and recent developments in antipsoriatic agents and molecular targets for therapeutic intervention - Preface, CUR PHARM D, 6(9), 2000, pp. NIL_2-NIL_2
Citation: Pe. Morris et Ga. Omura, Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasis, CUR PHARM D, 6(9), 2000, pp. 943-959
Citation: Ld. Morton et Jm. Pellock, Overview of childhood epilepsy and epileptic syndromes and advances in therapy, CUR PHARM D, 6(8), 2000, pp. 879-900